AIDS

Innovative Financing for Global Health R&D

in

R4D is identifying innovative approaches to financing global health R&D that reduce barriers and risk in the development of new health technologies. New and improved products are needed to reduce the burden of disease, but creating these products requires difficult long-term scientific efforts, with uncertain return on investment.

New and improved vaccines and drugs are urgently needed to reduce the burden of suffering and loss from diseases such as AIDS, tuberculosis, and malaria in developing countries. But creating these new health products requires extremely difficult long-term scientific efforts, and the markets for these kinds of life-saving vaccines and drugs are both uncertain and may not be very lucrative. Because of these barriers and risks, many scientific organizations and biopharmaceutical companies shy away from investing in these areas.

Main Contact: 
Robert Hecht
Duration: 
April, 2008 - December, 2012
Funder: 
International AIDS Vaccine Initiative
Status: 
Active
Staff Associated with Project: 
Aarthi Rao
Amrita Palriwala
Robert Hecht
Kimberly Manno Reott

R4D’s Affinity MacroFinance receives top honors at international finance competition

in
8 March, 2010

An initiative co-sponsored by the Results for Development Institute (R4D) and the Corporación Andina de Fomento (CAF) has won top honors at the Marketplace on Innovative Financial Solutions for Development, a competition hosted by the Agence Française de Développement (AFD), the Bill and Melinda Gates Foundation, and the World Bank.

Connected Expert(s): 
David de Ferranti
Connected Expert(s): 
David Stevens
Funder: 
Agence Française de Développement
Funder: 
The Bill and Melinda Gates Foundation
Funder: 
The World Bank
Attached File(s): 
application/pdf icon
Affinity MacroFinance 2016_The Year In Review.pdf

Impact on the Global Financial and Economic Crisis on the AIDS Response

in

The secretariat of the Health Financing Task Force at the Results for Development Institute prepared this paper for the 25th meeting of the UNAIDS Programme Coordinating Board to evaluate the impact of the global financial crisis on HIV/AIDS programs in developing countries.

The secretariat of the Health Financing Task Force at the Results for Development Institute prepared this paper for the 25th meeting of the UNAIDS Programme Coordinating Board to evaluate the impact of the global financial crisis on HIV/AIDS programs in developing countries.

Publication & Resource Type: 
Publications
Year Published: 
2009
Main Contact: 
Aarthi Rao
R4D Author(s): 
Aarthi Rao
R4D Author(s): 
Amrita Palriwala
R4D Author(s): 
Robert Hecht
Link to Publication-Resource: 
Read the Full Report

Critical Choices In Financing: The Response To The Global HIV/AIDS Pandemic

in

This paper examines potential long-term costs and financing options for the global AIDS response under four different scenarios and provides policy recommendations based on projected epidemiological and financial impacts.

This paper was published as part of the November/December 2009 edition of Health Affairs, a special issue focusing on the global response to the HIV/AIDS pandemic. The paper presents the findings of the aids2031 Costs and Financing Working Group, and addresses the following key questions: 

Publication & Resource Type: 
Journal Articles
Year Published: 
2009
Main Contact: 
Robert Hecht
R4D Author(s): 
Farzana Muhib
R4D Author(s): 
Robert Hecht
Author(s): 
Robert Hecht, Lori Bollinger, John Stover, William McGreevey, Farzana Muhib, Callisto Emas Madavo and David de Ferranti
Connected Project: 
aids2031: Costs and Financing Working Group
Link to Publication-Resource: 
Critical Choices In Financing

Farzana Muhib discusses aids2031 findings on the BBC's Health Check

in
23 November, 2009

In preparation for World AIDS Day, the BBC invited Farzana Muhib, R4D's coordinator for the aids2031 Costs and Financing Project, to discuss future cost and financing scenarios for the global AIDS epidemic in their Health Check spotlight, "The Future for HIV/AIDS Funding."  Ms. Muhib highlighted the importance of "tough choice" spending policy decisions and more efficient management of resources now in order to curb future costs of the epidemic and achieve better health outcomes.

Connected Expert(s): 
Farzana Muhib
Connected Project(s): 
aids2031: Costs and Financing Working Group
Connected Publications & Resources: 
Estimating Long-Term Global Resource Needs for AIDS through 2031
Fiscal Space and Political Space for Financing the Global AIDS Response to 2031
HIV and AIDS Programs - How they Support Health System Strengthening
The Evolution and Future of Donor Assistance for AIDS
The Future Role of the Philanthropy Sector Fighting AIDS
The Past, Present and Future of AIDS Resource Allocation
What Works to Prevent and Treat AIDS
Funder: 
UNAIDS

“Critical Choices in Financing” – Findings from AIDS2031 featured in Health Affairs

in
3 November, 2009

By the year 2031, the AIDS pandemic will enter its 50th year, and funding needed to fight the pandemic in developing countries could reach as much as $35 billion annually – unless wise choices are made today to spend more efficiently and focus on prevention activities that can lower the number of new infections in the future and moderate costs for treatment and other measures to mitigate the negative impacts of AIDS on individuals and their communities.

Connected Expert(s): 
David de Ferranti
Connected Expert(s): 
Farzana Muhib
Connected Expert(s): 
Robert Hecht
Connected Expert(s): 
William McGreevey
Connected Project(s): 
aids2031: Costs and Financing Working Group
Funder: 
The Norwegian Agency for Development Cooperation (NORAD)
Funder: 
UNAIDS

Eleven of the aids2031 technical reports series available now

in
30 September, 2009

The aids2031 Costs and Financing Project is pleased to be able to share eleven papers of our technical reports series. The papers address a range of issues including the estimation of future AIDS resource needs, the various options for financing, and the sociopolitical landscape in which AIDS programs are implemented. Papers are available for download here. A synthesis report combining the findings from the technical reports will be available in the coming months.

Connected Expert(s): 
Carleigh Krubiner
Connected Expert(s): 
Farzana Muhib
Connected Expert(s): 
Kira Thorien
Connected Expert(s): 
Robert Hecht
Connected Project(s): 
aids2031: Costs and Financing Working Group
Connected Publications & Resources: 
Assessing Costing and Prioritization in National AIDS Strategic Plans
Cost-Effective Interventions that Focus on Most-at-Risk Populations
Estimating Long-Term Global Resource Needs for AIDS through 2031
Fiscal Space and Political Space for Financing the Global AIDS Response to 2031
HIV and AIDS Programs - How they Support Health System Strengthening
Strategic Planning in Honduras: A Case Study
The Cost of Antiretrovirals
The Evolution and Future of Donor Assistance for AIDS
The Future Role of the Philanthropy Sector Fighting AIDS
The Past, Present and Future of AIDS Resource Allocation
What Works to Prevent and Treat AIDS

aids2031 presentation at ICAAP conference

in
4 September, 2009

R4D’s Farzana Muhib presented at the 9th International Congress on AIDS in Asia and the Pacific (ICAAP) conference in Bali, Indonesia on August 12, 2009. In her presentation, Farzana outlined the main findings of the aids2031 Costs and Financing Working Group, including Global and Asia-specific cost estimates for HIV/AIDS.

Her presentation can be downloaded below.

Connected Expert(s): 
Farzana Muhib
Connected Project(s): 
aids2031: Costs and Financing Working Group
Funder: 
UNAIDS
Attached File(s): 
application/vnd.ms-powerpoint icon
ICAAP presentation - Muhib - 12 Aug 2009.ppt

Estimating Long-Term Global Resource Needs for AIDS through 2031

in

This paper incorporates results from several of the aids2031 working groups to examine the costs and financial implications of changing the current approach to fighting HIV/AIDS.  It examines four different scenarios: Current Trends, Rapid Scale-up, Hard Choices for Prevention and Structural Change.

By 2031, the HIV/AIDS epidemic will enter its 50th year. In 1981, no one expected that the epidemic would become the challenge that the world faces today, particularly sub-Saharan Africa. Efforts to address the epidemic have increased dramatically over the last decade, but the epidemic remains. Without a change in approach, it is likely that the epidemic will still be with us in 2031.

Publication & Resource Type: 
Working Papers
Year Published: 
2009
Main Contact: 
Farzana Muhib
Author(s): 
John Stover & Lori Bollinger
Funder(s): 
UNAIDS
Connected Project: 
aids2031: Costs and Financing Working Group
Attached Publications & Resources: 
application/pdf icon
Estimating Long-Term Global Resource Needs for AIDS through 2031.pdf
Syndicate content